List of Tables
Summary Table: Global Market for Bioinformatics, by Application, Through 2028
Table 1: Recommendations for NGS Bioinformatics Tools
Table 2: Bioinformatics Tools Used for Metagenomics Analysis
Table 3: DBMS Platforms in Bioinformatics
Table 4: Global Market for Bioinformatics, by Application, Through 2028
Table 5: Cloud-Based Bioinformatics Tools
Table 6: Global Market for Bioinformatics in Genomics Applications, by Region, Through 2028
Table 7: Global Market for Bioinformatics in Proteomics Applications, by Region, Through 2028
Table 8: Global Market for Bioinformatics in Transcriptomics Applications, by Region, Through 2028
Table 9: Commercially Available Metabolomics Software
Table 10: Open Access Tools for Complex Liquid Chromatography-Mass Spectrometry Data Analysis
Table 11: Global Market for Bioinformatics in Metabolomics Applications, by Region, Through 2028
Table 12: Cheminformatics Software Solutions for Drug R&D
Table 13: Global Market for Bioinformatics in Cheminformatics Applications, by Region, Through 2028
Table 14: Pharmacogenomic Biomarkers in Drug Labeling
Table 15: Recent Research on Biomarkers, 2016-2023
Table 16: Global Market for Bioinformatics in Pharmacogenomics Applications, by Region, Through 2028
Table 17: Bioinformatics Tools and Databases Used in Pharmacogenomics
Table 18: Bioinformatics Tools for Pharmacogenomic Studies
Table 19: Tools for Metagenome Binning
Table 20: Global Market for Bioinformatics in Metagenomics Applications, by Region, Through 2028
Table 21: Planned or Ongoing Toxicogenomic Studies
Table 22: Global Market for Bioinformatics in Other Applications, by Region, Through 2028
Table 23: Global Market for Bioinformatics Sequencing Services and Platforms, by Segment, Through 2028
Table 24: Global Market for Bioinformatics Sequencing Services, by Region, Through 2028
Table 25: Sequence Analysis Software
Table 26: Global Market for Bioinformatics Sequencing Platforms, by Region, Through 2028
Table 27: Sequence Alignment Platforms
Table 28: Global Market for Bioinformatics, by Solution, Through 2028
Table 29: Global Market for Bioinformatics Hardware, by Type, Through 2028
Table 30: Global Market for Bioinformatics Services, by Region, Through 2028
Table 31: Bioinformatics Tools for Pharmacogenomic Software
Table 32: Toxicogenomic Studies Planned or Ongoing
Table 33: Archival Bioinformatics Databases
Table 34: Curative Bioinformatics Databases
Table 35: Commercially Available Bioinformatics Databases
Table 36: Biological Databases for Human Research
Table 37: Software for Biological Analysis
Table 38: Open-Source Bioinformatics Software
Table 39: NGS Platforms for Clinical Diagnostics
Table 40: Commonly Used Tools for NGS-Based DNA Analysis, by Functional Category
Table 41: Commercially Available Integrated DNA Analysis Solutions and Relevant Functionality
Table 42: Global Market for Bioinformatics Software, by Region, Through 2028
Table 43: High-Performance Computing Architectures: Advantages and Drawbacks
Table 44: Highest Performance Supercomputers, 2018
Table 45: SaaS Products
Table 46: Global Market for Bioinformatics Hardware, by Region, Through 2028
Table 47: Global Market for Bioinformatics Servers, by Region, Through 2028
Table 48: Global Market for High-Performance Computing Clusters, by Region, Through 2028
Table 49: Global Market for Storage Systems, by Region, Through 2028
Table 50: Global Market for Bioinformatics Appliances, by Region, Through 2028
Table 51: Global Market for Other Bioinformatics Hardware Types, by Region, Through 2028
Table 52: Global Market for Bioinformatics, by End Use, Through 2028
Table 53: Sequencing Data Analysis Bioinformatics Software and Tools
Table 54: Global Market for Bioinformatics for Research End Uses, by Region, Through 2028
Table 55: Global Market for Bioinformatics for Clinical and Medical End Uses, by Region, Through 2028
Table 56: Bioinformatics-Based Clinical and Medical Laboratory Information Management System
Table 57: Tools Used to Identify the Protein Structure in Bioinformatics for Healthcare Applications and Function
Table 58: Number of Therapeutic Drugs Developed Globally, by Disease Type, 2022
Table 59: Global Market for Other End Uses of Bioinformatics, by Region, Through 2028
Table 60: Global Market for Bioinformatics, by Region, Through 2028
Table 61: Number of Grants, by Type of Cancer, August 2023
Table 62: North American Market for Bioinformatics, by Country, Through 2028
Table 63: U.S. Market for Bioinformatics, by Solution, Through 2028
Table 64: U.S. Market for Bioinformatics, by Hardware Type, Through 2028
Table 65: U.S. Market for Sequencing Services and Platforms, Through 2028
Table 66: U.S. Market for Bioinformatics, by Application, Through 2028
Table 67: U.S. Market for Bioinformatics, by End Use, Through 2028
Table 68: Leading Bioinformatics Companies in the U.S.
Table 69: Venture Capital Companies Most Active in the Biotech Sector
Table 70: Canadian Market for Bioinformatics, by Solution, Through 2028
Table 71: Canadian Market for Bioinformatics, by Hardware Type, Through 2028
Table 72: Canadian Market for Sequencing Services and Platforms, Through 2028
Table 73: Canadian Market for Bioinformatics, by Application, Through 2028
Table 74: Canadian Market for Bioinformatics, by End Use, Through 2028
Table 75: Estimated New Male Cancer Cases in Canada, by Cancer Type, 2018
Table 76: Estimated New Female Cancer Cases in Canada, by Cancer Type, 2018
Table 77: Leading Canadian Bioinformatics Companies
Table 78: Mexican Market for Bioinformatics, by Solution, Through 2028
Table 79: Mexican Market for Bioinformatics, by Hardware Type, Through 2028
Table 80: Mexican Market for Sequencing Services and Platforms, Through 2028
Table 81: Mexican Market for Bioinformatics, by Application, Through 2028
Table 82: Mexican Market for Bioinformatics, by End Use, Through 2028
Table 83: European Market for Bioinformatics, by Country, Through 2028
Table 84: Leading European Bioinformatics Companies
Table 85: German Market for Bioinformatics, by Solution, Through 2028
Table 86: German Market for Bioinformatics, by Hardware Type, Through 2028
Table 87: German Market for Sequencing Services and Platforms, Through 2028
Table 88: German Market for Bioinformatics, by Application, Through 2028
Table 89: German Market for Bioinformatics, by End Use, Through 2028
Table 90: French Market for Bioinformatics, by Solution, Through 2028
Table 91: French Market for Bioinformatics, by Hardware Type, Through 2028
Table 92: French Market for Sequencing Services and Platforms, Through 2028
Table 93: French Market for Bioinformatics, by Application, Through 2028
Table 94: French Market for Bioinformatics, by End Use, Through 2028
Table 95: U.K. Market for Bioinformatics, by Solution, Through 2028
Table 96: U.K. Market for Bioinformatics, by Hardware Type, Through 2028
Table 97: U.K. Market for Sequencing Services and Platforms, Through 2028
Table 98: U.K. Market for Bioinformatics, by Application, Through 2028
Table 99: U.K. Market for Bioinformatics, by End Use, Through 2028
Table 100: Italian Market for Bioinformatics, by Solution, Through 2028
Table 101: Italian Market for Bioinformatics, by Hardware Type, Through 2028
Table 102: Italian Market for Sequencing Services and Platforms, Through 2028
Table 103: Italian Market for Bioinformatics, by Application, Through 2028
Table 104: Italian Market for Bioinformatics, by End Use, Through 2028
Table 105: Spanish Market for Bioinformatics, by Solution, Through 2028
Table 106: Spanish Market for Bioinformatics, by Hardware Type, Through 2028
Table 107: Spanish Market for Sequencing Services and Platforms, Through 2028
Table 108: Spanish Market for Bioinformatics, by Application, Through 2028
Table 109: Spanish Market for Bioinformatics, by End Use, Through 2028
Table 110: Rest of European Market for Bioinformatics, by Solution, Through 2028
Table 111: Rest of European Market for Bioinformatics, by Hardware Type, Through 2028
Table 112: Rest of European Market for Sequencing Services and Platforms, Through 2028
Table 113: Rest of European Market for Bioinformatics, by Application, Through 2028
Table 114: Rest of European Market for Bioinformatics, by End Use, Through 2028
Table 115: Asia-Pacific Market for Bioinformatics, by Country, Through 2028
Table 116: Japanese Market for Bioinformatics, by Solution, Through 2028
Table 117: Japanese Market for Bioinformatics, by Hardware Type, Through 2028
Table 118: Japanese Market for Sequencing Services and Platforms, Through 2028
Table 119: Japanese Market for Bioinformatics, by Application, Through 2028
Table 120: Japanese Market for Bioinformatics, by End Use, Through 2028
Table 121: Chinese Market for Bioinformatics, by Solution, Through 2028
Table 122: Chinese Market for Bioinformatics, by Hardware Type, Through 2028
Table 123: Chinese Market for Sequencing Services and Platforms, Through 2028
Table 124: Chinese Market for Bioinformatics, by Application, Through 2028
Table 125: Chinese Market for Bioinformatics, by End Use, Through 2028
Table 126: Indian Market for Bioinformatics, by Solution, Through 2028
Table 127: Indian Market for Bioinformatics, by Hardware Type, Through 2028
Table 128: Indian Market for Sequencing Services and Platforms, Through 2028
Table 129: Indian Market for Bioinformatics, by Application, Through 2028
Table 130: Indian Market for Bioinformatics, by End Use, Through 2028
Table 131: Leading Indian Bioinformatics Companies
Table 132: Australian and New Zealand Market for Bioinformatics, by Solution, Through 2028
Table 133: Australian and New Zealand Market for Bioinformatics, by Hardware Type, Through 2028
Table 134: Australian and New Zealand Market for Sequencing Services and Platforms, Through 2028
Table 135: Australian and New Zealand Market for Bioinformatics, by Application, Through 2028
Table 136: Australian and New Zealand Market for Bioinformatics, by End Use, Through 2028
Table 137: Rest of Asia-Pacific Market for Bioinformatics, by Solution, Through 2028
Table 138: Rest of Asia-Pacific Market for Bioinformatics, by Hardware Type, Through 2028
Table 139: Rest of Asia-Pacific Market for Sequencing Services and Platforms, Through 2028
Table 140: Rest of Asia-Pacific Market for Bioinformatics, by Application, Through 2028
Table 141: Rest of Asia-Pacific Market for Bioinformatics, by End Use, Through 2028
Table 142: Rest of the World Market for Bioinformatics, by Country, Through 2028
Table 143: Brazilian Market for Bioinformatics, by Solution, Through 2028
Table 144: Brazilian Market for Bioinformatics, by Hardware Type, Through 2028
Table 145: Brazilian Market for Sequencing Services and Platforms, Through 2028
Table 146: Brazilian Market for Bioinformatics, by Application, Through 2028
Table 147: Brazilian Market for Bioinformatics, by End Use, Through 2028
Table 148: GCC Countries Market for Bioinformatics, by Solution, Through 2028
Table 149: GCC Countries Market for Bioinformatics, by Hardware Type, Through 2028
Table 150: GCC Countries Market for Sequencing Services and Platforms, Through 2028
Table 151: GCC Countries Market for Bioinformatics, by Application, Through 2028
Table 152: GCC Countries Market for Bioinformatics, by End Use, Through 2028
Table 153: Other Rest of the World Countries Market for Bioinformatics, by Solution, Through 2028
Table 154: Other Rest of the World Countries Market for Bioinformatics, by Hardware Type, Through 2028
Table 155: Other Rest of the World Countries Market for Sequencing Services and Platforms, Through 2028
Table 156: Other Rest of the World Countries Market for Bioinformatics, by Application, Through 2028
Table 157: Other Rest of the World Countries Market for Bioinformatics, by End Use, Through 2028
Table 158: R&D Spending on Bioinformatics by Latin American Countries
Table 159: ESG Ratings and Metrics: Understanding the Data
Table 160: ESG Practices in the Bioinformatics Technologies
Table 161: ESG Social Performance
Table 162: ESG Governance Performance
Table 163: Recently Received Awards by Major Companies
Table 164: ESG Rankings for Major Bioinformatics Technologies Companies, 2023*
Table 165: Bioinformatics Databases
Table 166: Leading Drug Target Databases
Table 167: Computer Simulation Platforms
Table 168: Application of Cloud-Based Services in Healthcare
Table 169: Leading LIMS Providers
Table 170: Key Suppliers of ELNs
Table 171: Leading Absorption, Distribution, Metabolism, Excretion and Toxicity Prediction Tools
Table 172: Drug R&D Process Overview
Table 173: Leading EHR Providers, 2018
Table 174: Medical Applications for Healthcare Professionals
Table 175: Pharmaceutical and Bioinformatics Partnerships and Alliances, 2015-2020
Table 176: Emerging Trends of Bioinformatics Technologies
Table 177: Prominent Data Analysis Toolkits for Solving Problem of Data Science
Table 178: Recent Strategic Developments in the Bioinformatics Market, 2019-2023
Table 179: Public Funding Programs, 2012-2018
Table 180: Funding by European Bioinformatics Firms, 2021 and 2022
Table 181: Aitia: Product Portfolio
Table 182: Aitia: Recent Developments, 2015-2023
Table 183: Agilent Technologies Inc.: Product Portfolio
Table 184: Aragen Life Sciences Ltd.: Product Portfolio
Table 185: Biomatters Ltd.: Product Portfolio
Table 186: Bio-Rad: Product Portfolio
Table 187: Bio-Techne: Product Portfolio
Table 188: Compugen Ltd.: Product Portfolio
Table 189: Dassault Systemes Biovia: Product Portfolio
Table 190: DNAStar Inc.: Product Portfolio
Table 191: DNAStar Inc.: Recent Developments, 2016-2022
Table 192: Genedata AG: Product Portfolio
Table 193: Genedata AG: Recent Developments, 2017-2023
Table 194: Geneva Informatics (GeneBio) SA: Product Portfolio
Table 195: Illumina Inc.: Product Portfolio
Table 196: Inte:Ligand Software Entwicklungs Und Consulting GmbH: Product Portfolio
Table 197: MacVector Inc.: Product Portfolio
Table 198: Molecular Connections Pvt. Ltd.: Product Portfolio
Table 199: Molecular Networks GmbH: Product Portfolio
Table 200: Nonlinear Dynamics Ltd.: Product Portfolio
Table 201: Ocimum Biosolutions Ltd.: Product Portfolio
Table 202: PerkinElmer Informatics Inc.: Product Portfolio
Table 203: Personalis Inc.: Product Portfolio
Table 204: Qlucore AB: Product Portfolio
Table 205: Qlucore AB: Recent Developments, 2018
Table 206: Real Time Genomics Inc.: Product Portfolio
Table 207: Real Time Genomics Inc.: Recent Developments, 2016
Table 208: SmartGene Services SARL: Product Portfolio
Table 209: Syngene International Ltd.: Product Portfolio
Table 210: Syngene International Ltd.: Recent Developments, 2016-2023
Table 211: Thermo Fisher Scientific Inc.: Product Portfolio
Table 212: Acronyms Used in This Report
List of Figures
Summary Figure: Global Market Shares of Bioinformatics, by Application, 2022
Figure 1: Bioinformatics Relationship with Omic Technologies
Figure 2: Schematic Representation of Biology Systems and Translational Bioinformatics
Figure 3: Principles of Precision Medicine
Figure 4: Recent FDA-Approved Cell-Based Therapies
Figure 5: Applications of Bioinformatics in Drug Development
Figure 6: Collaboration within the Bioinformatics Sector, by Country, Since 2016
Figure 7: Number of FDA CDER Drug Approvals, 2008-2020
Figure 8: Drug Product Approvals in Europe and the U.S., 2020
Figure 9: CDER’s Annual Novel Drug Approvals, 2009-2019
Figure 10: Investment by Genome Canada, Since 2000
Figure 11: Major Socioeconomic and Political Factors Negatively Influencing the Bioinformatics Market
Figure 12: The Four Dimensions of Big Data
Figure 13: Software Scalability of Big Data Bioinformatics
Figure 14: Software Validation of Big Data Bioinformatics
Figure 15: Global Market Shares of Bioinformatics, by Application, 2022
Figure 16: Global Market Shares of Bioinformatics, by Application, 2028
Figure 17: Standard Antibody Sequencing Service Process
Figure 18: Global Market for Bioinformatics in Genomics Applications, 2020-2028
Figure 19: Global Market for Bioinformatics in Genomics Applications, by Region, 2020-2028
Figure 20: Distribution of Cancer Incidence, by Cancer Type, 2020
Figure 21: Top-Down Proteomics Approach
Figure 22: Global Demand for EMBL-EBI Data, 2018-2022
Figure 23: Global Market for Bioinformatics in Proteomics Applications, 2020-2028
Figure 24: Global Market for Bioinformatics in Proteomics Applications, by Region, 2020-2028
Figure 25: Global Market for Bioinformatics in Transcriptomics Applications, 2020-2028
Figure 26: Global Market for Bioinformatics in Transcriptomics Applications, by Region, 2020-2028
Figure 27: Global Market for Bioinformatics in Metabolomics Applications, 2020-2028
Figure 28: Global Market for Bioinformatics in Metabolomics Applications, by Region, 2020-2028
Figure 29: Global Market for Bioinformatics in Cheminformatics Applications, 2020-2028
Figure 30: Global Market for Bioinformatics in Cheminformatics Applications, by Region, 2020-2028
Figure 31: Global Market for Bioinformatics in Pharmacogenomics Applications, 2020-2028
Figure 32: Global Market for Bioinformatics in Pharmacogenomics Applications, by Region, 2020-2028
Figure 33: Global Market for Bioinformatics in Metagenomics Applications, 2020-2028
Figure 34: Global Market for Bioinformatics in Metagenomics Applications, by Region, 2020-2028
Figure 35: Global Market for Bioinformatics in Other Applications, 2020-2028
Figure 36: Global Market for Bioinformatics in Other Applications, by Region, 2020-2028
Figure 37: Global Market Shares of Bioinformatics Sequencing Services and Platforms, by Segment, 2022
Figure 38: Global Market Shares of Bioinformatics Sequencing Services and Platforms, by Segment, 2028
Figure 39: Global Market for Bioinformatics Sequencing Services, 2020-2028
Figure 40: Global Market for Bioinformatics Sequencing Services, by Region, 2020-2028
Figure 41: Global Market for Bioinformatics Sequencing Platforms, 2020-2028
Figure 42: Global Market for Bioinformatics Sequencing Platforms, by Region, 2020-2028
Figure 43: Global Market Shares of Bioinformatics, by Solution, 2022
Figure 44: Global Market Shares of Bioinformatics, by Solution, 2028
Figure 45: Global Market Shares of Bioinformatics Hardware, by Type, 2022
Figure 46: Global Market Shares of Bioinformatics Hardware, by Type, 2028
Figure 47: Global Market for Bioinformatics Services, 2020-2028
Figure 48: Global Market for Bioinformatics Tools and Database Services, by Region, 2020-2028
Figure 49: European Bioinformatics Institute Software Solutions
Figure 50: Global Market for Bioinformatics Software, 2020-2028
Figure 51: Global Market for Bioinformatics Software, by Region 2020-2028
Figure 52: Evolution of Information Technology Infrastructure
Figure 53: Schematic Representation of Cloud Computing Services
Figure 54: Global Market for Bioinformatics Hardware, 2020-2028
Figure 55: Global Market for Bioinformatics Hardware, by Region, 2020-2028
Figure 56: Global Market Shares of Bioinformatics, by End Use, 2022
Figure 57: Global Market Shares of Bioinformatics, by End Use, 2028
Figure 58: Global Incidence of Patients with Chronic Diseases, 2005-2030
Figure 59: Global Market for Bioinformatics for Research End Uses, 2020-2028
Figure 60: Global Market for Bioinformatics for Research End Uses, by Region, 2020-2028
Figure 61: Global Market for Bioinformatics for Clinical and Medical End Uses, 2020-2028
Figure 62: Global Market for Bioinformatics for Clinical and Medical End Uses, by Region, 2020-2028
Figure 63: Clinical Bioinformatics for Patients for Precision Health
Figure 64: Estimate of Biopharmaceutical R&D Spending, 2012-2026
Figure 65: Number of Therapeutic Drugs Developed Globally, by Disease Type, 2022
Figure 66: Global Market for Other End Uses of Bioinformatics, 2020-2028
Figure 67: Global Market for Other End Uses of Bioinformatics, by Region, 2020-2028
Figure 68: Classical and Digital Forensics with Respect to Bioinformatics
Figure 69: Global Market Shares of Bioinformatics, by Region, 2022
Figure 70: Global Market Shares of Bioinformatics, by Region, 2028
Figure 71: North American Market Shares of Bioinformatics, by Solution, 2022
Figure 72: North American Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 73: North American Market Shares of Sequencing Services and Platforms, 2022
Figure 74: North American Market Shares of Bioinformatics, by Application, 2022
Figure 75: North American Market Shares of Bioinformatics, by End Use, 2022
Figure 76: North American Market Shares of Bioinformatics, by Country, 2022
Figure 77: U.S. Market for Bioinformatics, 2020-2028
Figure 78: U.S. Market Shares of Bioinformatics, by Solution, 2022
Figure 79: U.S. Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 80: U.S. Market Shares of Sequencing Services and Platforms, 2022
Figure 81: U.S. Market Shares of Bioinformatics, by Application, 2022
Figure 82: U.S. Market Shares of Bioinformatics, by End Use, 2022
Figure 83: Canadian Market for Bioinformatics, 2020-2028
Figure 84: Canadian Market Shares of Bioinformatics, by Solution, 2022
Figure 85: Canadian Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 86: Canadian Market Shares of Bioinformatics Sequencing Services and Platforms, 2022
Figure 87: Canadian Market Shares of Bioinformatics, by Application, 2022
Figure 88: Canadian Market Shares of Bioinformatics, by End Use, 2022
Figure 89: Mexican Market for Bioinformatics, 2020-2028
Figure 90: Mexican Market Shares of Bioinformatics, by Solution, 2022
Figure 91: Mexican Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 92: Mexican Market Shares of Sequencing Services and Platforms, 2022
Figure 93: Mexican Market Shares of Bioinformatics, by Application, 2022
Figure 94: Mexican Market Shares of Bioinformatics, by End Use, 2022
Figure 95: European Market Shares of Bioinformatics, by Solution, 2022
Figure 96: European Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 97: European Market Shares of Sequencing Services and Platforms, 2022
Figure 98: European Market Shares of Bioinformatics, by Application, 2022
Figure 99: European Market Shares of Bioinformatics, by End Use, 2022
Figure 100: European Market Shares of Bioinformatics, by Country, 2022
Figure 101: German Market for Bioinformatics, 2020-2028
Figure 102: German Market Shares of Bioinformatics, by Solution, 2022
Figure 103: German Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 104: German Market Shares of Sequencing Services and Platforms, 2022
Figure 105: German Market Shares of Bioinformatics, by Application, 2022
Figure 106: German Market Shares of Bioinformatics, by End Use, 2022
Figure 107: Current Molecular-Experimental, Epidemiological and Analytical Tools Applied in Systems Medicine
Figure 108: French Market for Bioinformatics, 2020-2028
Figure 109: French Market Shares of Bioinformatics, by Solution, 2022
Figure 110: French Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 111: French Market Shares of Sequencing Services and Platforms, 2022
Figure 112: French Market Shares of Bioinformatics, by Application, 2022
Figure 113: French Market Shares of Bioinformatics, by End Use, 2022
Figure 114: Healthcare Spending and Financing in France, 2019 and 2050
Figure 115: U.K. Market for Bioinformatics, 2020-2028
Figure 116: U.K. Market Shares of Bioinformatics, by Solution, 2022
Figure 117: U.K. Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 118: U.K. Market Shares of Sequencing Services and Platforms, 2022
Figure 119: U.K. Market Shares of Bioinformatics, by Application, 2022
Figure 120: U.K. Market Shares of Bioinformatics, by End Use, 2022
Figure 121: Italian Market for Bioinformatics, 2020-2028
Figure 122: Italian Market Shares of Bioinformatics, by Solution, 2022
Figure 123: Italian Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 124: Italian Market Shares of Sequencing Services and Platforms, 2022
Figure 125: Italian Market Shares of Bioinformatics, by Application, 2022
Figure 126: Italian Market Shares of Bioinformatics, by End Use, 2022
Figure 127: Spanish Market for Bioinformatics, 2020-2028
Figure 128: Spanish Market Shares of Bioinformatics, by Solution, 2022
Figure 129: Spanish Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 130: Spanish Market Shares of Sequencing Services and Platforms, 2022
Figure 131: Spanish Market Shares of Bioinformatics, by Application, 2022
Figure 132: Spanish Market Shares of Bioinformatics, by End Use, 2022
Figure 133: Rest of European Market for Bioinformatics, 2020-2028
Figure 134: Rest of European Market Shares of Bioinformatics, by Solution, 2022
Figure 135: Rest of European Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 136: Rest of European Market Shares of Sequencing Services and Platforms, 2022
Figure 137: Rest of European Market Shares of Bioinformatics, by Application, 2022
Figure 138: Rest of European Market Shares of Bioinformatics, by End Use, 2022
Figure 139: Asia-Pacific Market Shares of Bioinformatics, by Solution, 2022
Figure 140: Asia-Pacific Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 141: Asia-Pacific Market Shares of Sequencing Services and Platforms, 2022
Figure 142: Asia-Pacific Market Shares of Bioinformatics, by Application, 2022
Figure 143: Asia-Pacific Market Shares of Bioinformatics, by End Use, 2022
Figure 144: Asia-Pacific Market Shares of Bioinformatics, by Country, 2022
Figure 145: Japanese Market for Bioinformatics, 2020-2028
Figure 146: Japanese Market Shares of Bioinformatics, by Solution, 2022
Figure 147: Japanese Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 148: Japanese Market Shares of Sequencing Services and Platforms, 2022
Figure 149: Japanese Market Shares of Bioinformatics, by Application, 2022
Figure 150: Japanese Market Shares of Bioinformatics, by End Use, 2022
Figure 151: Chinese Market for Bioinformatics, 2020-2028
Figure 152: Chinese Market Shares of Bioinformatics, by Solution, 2022
Figure 153: Chinese Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 154: Chinese Market Shares of Sequencing Services and Platforms, 2022
Figure 155: Chinese Market Shares of Bioinformatics, by Application, 2022
Figure 156: Chinese Market Shares of Bioinformatics, by End Use, 2022
Figure 157: Indian Market for Bioinformatics, 2020-2028
Figure 158: Indian Market Shares of Bioinformatics, by Solution, 2022
Figure 159: Indian Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 160: Indian Market Shares of Sequencing Services and Platforms, 2022
Figure 161: Indian Market Shares of Bioinformatics, by Application, 2022
Figure 162: Indian Market Shares of Bioinformatics, by End Use, 2022
Figure 163: Key Areas of Research Utilizing Bioinformatics
Figure 164: Australian and New Zealand Market for Bioinformatics, 2020-2028
Figure 165: Australian and New Zealand Market Shares of Bioinformatics, by Solution, 2022
Figure 166: Australian and New Zealand Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 167: Australian and New Zealand Market Shares of Sequencing Services and Platforms, 2022
Figure 168: Australian and New Zealand Market Shares of Bioinformatics, by Application, 2022
Figure 169: Australian and New Zealand Market Shares of Bioinformatics, by End Use, 2022
Figure 170: Rest of Asia-Pacific Market for Bioinformatics, 2020-2028
Figure 171: Rest of Asia-Pacific Market Shares of Bioinformatics, by Solution, 2022
Figure 172: Rest of Asia-Pacific Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 173: Rest of Asia-Pacific Market Shares of Sequencing Services and Platforms, 2022
Figure 174: Rest of Asia-Pacific Market Shares of Bioinformatics, by Application, 2022
Figure 175: Rest of Asia-Pacific Market Shares of Bioinformatics, by End Use, 2022
Figure 176: Rest of the World Market Shares of Bioinformatics, by Solution, 2022
Figure 177: Rest of the World Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 178: Rest of the World Market Shares of Sequencing Services and Platforms, 2022
Figure 179: Rest of the World Market Shares of Bioinformatics, by Application, 2022
Figure 180: Rest of the World Market Shares of Bioinformatics, by End Use, 2022
Figure 181: Rest of the World Market Shares of Bioinformatics, by Country, 2019
Figure 182: Brazilian Market for Bioinformatics, 2020-2028
Figure 183: Brazilian Market Shares of Bioinformatics, by Solution, 2022
Figure 184: Brazilian Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 185: Brazilian Market Shares of Sequencing Services and Platforms, 2022
Figure 186: Brazilian Market Shares of Sequencing Services and Platforms, 2022
Figure 187: Brazilian Market Shares of Bioinformatics, by End Use, 2022
Figure 188: GCC Countries Market for Bioinformatics, 2020-2028
Figure 189: GCC Countries Market Shares of Bioinformatics, by Solution, 2022
Figure 190: GCC Countries Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 191: GCC Countries Market Shares of Sequencing Services and Platforms, 2022
Figure 192: GCC Countries Market Shares of Bioinformatics, by Application, 2022
Figure 193: GCC Countries Market Shares of Bioinformatics, by End Use, 2022
Figure 194: Other Rest of the World Countries Market for Bioinformatics, 2020-2028
Figure 195: Other Rest of the World Countries Market Shares of Bioinformatics, by Solution, 2022
Figure 196: Other Rest of the World Countries Market Shares of Bioinformatics, by Hardware Type, 2022
Figure 197: Other Rest of the World Countries Market Shares of Sequencing Services and Platforms, 2022
Figure 198: Other Rest of the World Countries Market Shares of Bioinformatics, by Application, 2022
Figure 199: Other Rest of the World Countries Market Shares of Bioinformatics, by End Use, 2022
Figure 200: Number of Research Articles Published by Scientists from 19 Latin American Countries on Bioinformatics and Computational Biology, 1991-2016
Figure 201: Policy, Infrastructure, Training and Funding Landscape of Computational Biology in South Africa, 2000-Present
Figure 202: Snapshot of Key ESG Trends in the Bioinformatics Technologies Industry
Figure 203: PerkinElmer Informatics Inc.: ESG Priorities Matrix
Figure 204: Bio-Rad Laboratories Inc.: ESG Priorities Matrix
Figure 205: Drug Development Process
Figure 206: Phases in the Drug Discovery and Development Process
Figure 207: Phase Transition Success Rates and Likelihood of Approvals for All Modalities and Medicines
Figure 208: Steps in Drug Discovery
Figure 209: Information Systems within the Laboratory Architecture
Figure 210: Application of Bioinformatics in Clinical Trials
Figure 211: Snapshot of Key Trends in the Growth of Diabetes Medical Devices
Figure 212: Snapshot of Key Trends in the Growth of Bioinformatics Technologies
Figure 213: Classification of Soft Computing Approach
Figure 214: Investment by Genome Canada, Since 2000
Figure 215: Global Market Ranking of Bioinformatics Manufacturers, 2019
Figure 216: Agilent Technologies Inc.: Annual Revenue, 2016-2022
Figure 217: Agilent Technologies Inc.: Revenue Share, by Region/Country, 2022
Figure 218: Agilent Technologies Inc.: Revenue Share, by Business Segment, 2022
Figure 219: Aragen Life Sciences Ltd.: Annual Revenue, 2021 and 2022
Figure 220: Bio-Rad: Annual Revenue, 2016-2022
Figure 221: Bio-Rad: Revenue Share, by Region, 2022
Figure 222: Bio-Rad: Revenue Share, by Business Unit, 2022
Figure 223: Bio-Techne: Annual Revenue, 2016-2022
Figure 224: Bio-Techne: Revenue Share, by Region/Country, 2022
Figure 225: Bio-Techne: Revenue Share, by Business Segment, 2022
Figure 226: Illumina Inc.: Annual Revenue, 2018-2022
Figure 227: Illumina Inc.: Revenue Share, by Region/Country, 2022
Figure 228: Illumina Inc.: Revenue Share, by Business Segment, 2022
Figure 229: PerkinElmer Informatics Inc: Revenue Share, by Region/Country, 2022
Figure 230: Personalis Inc.: Revenue Share, by Region/Country, 2022
Figure 231: Syngene International Ltd.: Annual Revenue, 2021-2022
Figure 232: Syngene International Ltd.: Revenue Share, by Region/Country, 2022
Figure 233: Thermo Fisher Scientific Inc.: Annual Revenue, 2016-2022
Figure 234: Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022
Figure 235: Thermo Fisher Scientific Inc.: Revenue Share, by Business Segment, 2022
